Tofigh Darou Research and Engineering Company
Tofigh Darou Research and Engineering Company is Iran's largest pharmaceutical R&D center and a subsidiary of TIPICO holding, developing and manufacturing Active Pharmaceutical Ingredients across eight therapeutic categories plus peptide and bone graft products for domestic and international B2B pharmaceutical buyers.
- Company typePrivate
- Founded1999
- HeadquartersTehran, Iran
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tofigh Darou Research and Engineering Company does
Tofigh Darou Research and Engineering Company (توفیق دارو), founded in 1999 and headquartered in Tehran, Iran, is a knowledge-based pharmaceutical research and engineering firm that operates as the dedicated R&D center of TIPICO (Iran Pharmaceutical Equipment Company), Iran's largest pharmaceutical holding. The company designs, develops, and produces Active Pharmaceutical Ingredients (APIs) across eight therapeutic categories — anti-cancer, cardiovascular, neurological, anti-diabetic, antiviral, immune system, peptide-based, and narcotic/analgesic products — along with finished dosage forms. Approximately 60 pharmaceutical innovations have been developed in-house over its ~26-year operating history, supported by capabilities in API synthesis, peptide chemistry (including complex molecules such as Semaglutide, Octreotide, and Triptorelin), molecular biology, and drug discovery. The firm also operates Todabin (تودابین), a wholly-owned adjacent subsidiary producing next-generation bioactive bone grafts for orthopedic and maxillofacial applications.
The company's business model combines B2B API and finished-dose supply to domestic Iranian pharmaceutical manufacturers with export of selected APIs and technical know-how to international markets. Revenue is generated through three principal streams: (1) API manufacturing and sale, (2) licensing and export of proprietary technical knowledge and products, and (3) contract research, industrial site construction, and manufacturing setup services. Pricing is not publicly disclosed. The go-to-market motion is enterprise field sales, with visibility at industry exhibitions (Iran Pharma, Pharmex, Iran Health), direct engagement with international delegations, and participation in public tenders. The company employs 51–100 staff and is supervised by Iran's Ministry of Cooperatives, Labor and Social Welfare.
Tofigh Darou positions itself as Iran's largest pharmaceutical R&D center and a strategic national asset for reducing import dependency on APIs and high-technology medicines. Its customer base is institutional — primarily domestic pharmaceutical manufacturers and selected international buyers — while ultimate end-users are healthcare providers and patients across Iran and select export markets.
Tofigh Darou Research and Engineering Company firmographics
Firmographics- Name
- Tofigh Darou Research and Engineering Company
- Legal name
- Tofigh Darou Research and Engineering Company (شرکت تحقیقاتی مهندسی توفیق دارو)
- Website
- https://todaco.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Tofigh Darou Research and Engineering Company is Iran's largest pharmaceutical R&D center and a subsidiary of TIPICO holding, developing and manufacturing Active Pharmaceutical Ingredients across eight therapeutic categories plus peptide and bone graft products for domestic and international B2B pharmaceutical buyers.
- Ownership category
- akta.pro rank
Tofigh Darou Research and Engineering Company industry classification
Industry- Product category
- Active Pharmaceutical Ingredients
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industry
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
Keywords
Where Tofigh Darou Research and Engineering Company is headquartered
LocationHeadquarters
- HQ city
- Tehran
- HQ country
- Iran
- HQ region
- Middle East
Offices1 record
Markets served
Tofigh Darou Research and Engineering Company business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- API Manufacturing and Sale: Design, development, and production of active pharmaceutical ingredients (APIs) across multiple therapeutic categories for domestic pharmaceutical companies and export markets. This is the primary revenue stream.
- Export of Technical Know-How and Products: Export of proprietary technical knowledge and selected pharmaceutical products to international markets, generating foreign revenue and positioning Iran in the global pharmaceutical value chain.
- Contract Research and Project Execution: R&D project execution, industrial site construction, and manufacturing setup services for pharmaceutical production facilities, conducted as a research engineering company under TIPICO.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Tofigh Darou Research and Engineering Company product offering
Product offeringCore offering
Tofigh Darou manufactures and supplies Active Pharmaceutical Ingredients (APIs) and finished dosage pharmaceutical products across multiple therapeutic categories including oncology, cardiovascular, anti-diabetic, neurological, antiviral, immune system, peptide-based, and narcotic therapies. The company also develops specialty products such as bioactive bone grafts and offers contract research services alongside export of proprietary technical know-how to international pharmaceutical clients.
Product overview
Tofigh Darou Research and Engineering Company is Iran's largest pharmaceutical research center and a knowledge-based enterprise. The company operates as a comprehensive pharmaceutical manufacturer producing Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical products. The portfolio spans multiple therapeutic categories: Anti-Cancer products (8 oncology medications), Cardiovascular products (9 products including Apixaban, Rivaroxaban), Anti-Diabetic products (5 medications), Neurological products (4 medications), Immune System products (8 medications), Antiviral products, Peptide-based medications (7 products), Narcotic/analgesic products (4 medications), and Miscellaneous products (6 items). Additionally, the company offers Todabin (تودابن), a next-generation bioactive bone graft medical device for orthopedic and maxillofacial applications. The company serves as Tipico Holding's research and development center and exports both technical knowledge and products to international markets. Approximately 60 pharmaceutical innovations have been developed by the company's elite researchers.
Differentiator
Problem solved
Functional benefit
Brands
- Todabin (تودابن): Medical equipment brand - next generation bioactive bone grafts for bone reconstruction in maxillofacial surgery and orthopedics
Products and services
- Anti-Cancer Pharmaceutical Products A line of Active Pharmaceutical Ingredients and finished oncology formulations developed for pharmaceutical manufacturers and healthcare providers.
- Cardiovascular Pharmaceutical Products Cardiovascular Active Pharmaceutical Ingredients and finished dosage forms such as Apixaban and similar molecules supplied to pharmaceutical manufacturers.
- Anti-Diabetic Pharmaceutical Products Active Pharmaceutical Ingredients and finished dosage forms targeting diabetes management, supplied to pharmaceutical manufacturers.
- Neurological Pharmaceutical Products Neurological Active Pharmaceutical Ingredients and finished dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
- Antiviral Pharmaceutical Products Antiviral Active Pharmaceutical Ingredients and finished dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
- Immune System Pharmaceutical Products Immunology-related Active Pharmaceutical Ingredients and finished dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
- Peptide-Based Pharmaceutical Products Peptide Active Pharmaceutical Ingredients and finished peptide-based dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
- Narcotic Pharmaceutical Products Controlled narcotic Active Pharmaceutical Ingredients and finished dosage forms supplied to licensed pharmaceutical manufacturers and healthcare providers.
- Miscellaneous Pharmaceutical Products Miscellaneous Active Pharmaceutical Ingredients and finished dosage forms not classified under the company's primary therapeutic categories.
- Todabin Bioactive Bone Graft Specialty bioactive bone graft product for orthopedic and dental applications, supplied to medical device distributors and healthcare providers.
- Contract Research and Project Execution Services Contract pharmaceutical research, process development, and project execution services provided to pharmaceutical manufacturers seeking R&D partnership.
- Export of Technical Know-How and Products International licensing and technology transfer offering covering proprietary pharmaceutical manufacturing know-how and finished products supplied to overseas pharmaceutical clients.
Quantifiable outcome
- Approximately 60 pharmaceutical innovations developed and delivered to patients in Iran and globally
- +1 more outcomes
Companies that use Tofigh Darou Research and Engineering Company
Customer profileSegments2 records
Ideal customer profiles3 records
Tofigh Darou Research and Engineering Company technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Tofigh Darou Research and Engineering Company partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TIPICO (Tajhizat Pezeshki Iran — Iran Pharmaceutical Equipment Company)coreTofigh Darou serves as the R&D center of TIPICO, Iran's largest pharmaceutical holding company. As an integral part of TIPICO, the company contributes to the holding's broader mission of pharmaceutical development, manufacturing, and export. TIPICO oversees the company's strategic direction within Iran's largest pharmaceutical ecosystem.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Tofigh Darou Research and Engineering Company competitors and assessment
Company assessmentRegional players
- Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generics and APIs regionally. Comparable as a regional Middle East branded-pharma peer operating in adjacent GCC markets under similar regulatory dynamics.
- SPIMACO Addwaeih: Saudi Arabia's largest pharmaceutical manufacturer, producing APIs and finished dosage forms across broad therapeutic categories. Comparable as a regional Middle East peer with diversified API + branded pharma operations similar to Tofigh Darou.
Others
- Dr. Reddy's Laboratories: India-based global pharmaceutical company with API manufacturing and finished formulations across multiple therapeutic areas including oncology and cardiovascular. Comparable as a broad incumbent with similar multi-category API + branded strategy.
Direct peers
- Divis Laboratories: India-based pure-play API manufacturer specializing in complex, high-value APIs including peptides and cardiovascular compounds. Closely comparable to Tofigh Darou's API-centric, multi-therapeutic, peptide-capable business model.
- Sobhan Oncology: Iranian specialty pharmaceutical manufacturer focused on oncology products. Directly comparable given Tofigh Darou's anti-cancer API category (Elapirib, Bortezomib, Pomalidomide, Thalidomide, Temozolomide) overlaps with Sobhan's oncology focus.
- Barakat Pharmaceutical: Iranian pharmaceutical holding with API and finished-dose capabilities across multiple therapeutic categories. Directly comparable as a domestic Iranian API/formulation competitor serving the same national self-sufficiency mandate.
- Darou Pakhsh Pharma: Iran's largest pharmaceutical manufacturer by sales; produces a broad portfolio of finished drugs across multiple therapeutic categories in Iran. Directly comparable as a domestic Iranian pharma producing across overlapping therapeutic areas and serving the same formulator/provider customers.
Broad incumbents
- Hikma Pharmaceuticals: Jordan-headquartered multinational specialty pharma with strong Middle East footprint in generics, injectables, and branded products. Comparable as a regional incumbent operating across overlapping therapeutic categories and serving MENA markets.
- Aurobindo Pharma: India-based global API and generics manufacturer with deep expertise in small-molecule API synthesis across cardiovascular, anti-diabetic, oncology, and CNS categories. Comparable as a large-scale multi-therapeutic API manufacturer.
- Cipla: India-headquartered global pharmaceutical manufacturer with broad API and finished-dose operations including respiratory, cardiovascular, and oncology. Comparable as a multi-therapeutic branded pharma + API incumbent in emerging markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Tofigh Darou Research and Engineering Company social profiles
Digital presenceTofigh Darou Research and Engineering Company financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tofigh Darou Research and Engineering Company leadership team
Management profileNumber of profiles
Profiles3 records
Tofigh Darou Research and Engineering Company subsidiaries and ownership
Company hierarchySubsidiaries1 record
Tofigh Darou Research and Engineering Company funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tofigh Darou Research and Engineering Company M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tofigh Darou Research and Engineering Company
What does Tofigh Darou Research and Engineering Company do?
Tofigh Darou manufactures and supplies Active Pharmaceutical Ingredients (APIs) and finished dosage pharmaceutical products across multiple therapeutic categories including oncology, cardiovascular, anti-diabetic, neurological, antiviral, immune system, peptide-based, and narcotic therapies. The company also develops specialty products such as bioactive bone grafts and offers contract research services alongside export of proprietary technical know-how to international pharmaceutical clients.
Is Tofigh Darou Research and Engineering Company a public or private company?
Tofigh Darou Research and Engineering Company is a private company. It is classified as corporate owned and is currently operating.
When was Tofigh Darou Research and Engineering Company founded?
Tofigh Darou Research and Engineering Company was founded in 1999. It employs 51 to 100 people.
Where is Tofigh Darou Research and Engineering Company based?
Tofigh Darou Research and Engineering Company is headquartered in Tehran, Iran, in the Middle East region.
How does Tofigh Darou Research and Engineering Company make money?
Three revenue lines are on record. API Manufacturing and Sale is the primary driver. The others are export of Technical Know-How and Products and contract Research and Project Execution.
Who are Tofigh Darou Research and Engineering Company's main competitors?
Regional players on record are Julphar (Gulf Pharmaceutical Industries) and SPIMACO Addwaeih. Dr. Reddy's Laboratories is listed as an others. Direct peers are Divis Laboratories, Sobhan Oncology, Barakat Pharmaceutical and Darou Pakhsh Pharma. Broad incumbents are Hikma Pharmaceuticals, Aurobindo Pharma and Cipla.
Does Tofigh Darou Research and Engineering Company have an API?
No public API is recorded for Tofigh Darou Research and Engineering Company.
What industry is Tofigh Darou Research and Engineering Company in?
Tofigh Darou Research and Engineering Company's product category is Active Pharmaceutical Ingredients. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 325412 and its SIC code is 2834.